Hamilton Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$368K Buy
4,045
+419
+12% +$38.3K 0.02% 85
2025
Q1
$340K Buy
3,626
+363
+11% +$32.5K 0.02% 86
2024
Q4
$297K Buy
3,263
+870
+36% +$83K 0.02% 88
2024
Q3
$224K Buy
2,393
+18
+0.8% +$1.83K 0.02% 117
2024
Q2
$230K Sell
2,375
-83
-3% -$7.66K 0.02% 105
2024
Q1
$221K Sell
2,458
-127
-5% -$10.8K 0.02% 125
2023
Q4
$206K Buy
+2,585
New +$194K 0.02% 126

Other funds holding CL

Hamilton Capital's CL Position: Q2 2025 in Review

Hamilton Capital increased its Colgate-Palmolive (CL) stake by 12% in Q2 2025, buying an estimated $38.3K and bringing the position to 4,045 shares worth $368K. The position accounts for 0.02% of the portfolio, ranked #85.

Hamilton Capital first reported a position in CL in Q4 2023 and has held it in 7 quarters since. 1,913 funds tracked by Wall St. Rank hold CL as of Q2 2025.

  • Hamilton Capital held 4,045 shares of Colgate-Palmolive worth $368K as of Q2 2025.
  • Hamilton Capital bought 419 Colgate-Palmolive shares in Q2 2025, an estimated $38.3K.
  • Colgate-Palmolive made up 0.02% of Hamilton Capital's portfolio in Q2 2025, its #85 holding.
  • Hamilton Capital first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 7 quarters since.
  • 1,913 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on Hamilton Capital's 13F filing for Q2 2025, filed 14 Aug 2025.